Surgical Resection
Gauden AJ, Hunn A, Erasmus A, et al. Combined modality treatment of newly diagnosed glioblastoma multiforme in a regional neurosurgical centre. J Clin Neurosci. 2009;16:1174-1179. Epub 2009 Jun 18.

Martinez R, Janka M, Soldner F, Behr R. Gross-total resection of malignant gliomas in elderly patients: implications in survival. Zentralbl Neurochir. 2007;68:176-181. Epub 2007 Oct 26.

Genetic Markers
Balik V, Mirossay P, Bohus P, et al. Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy. Cell Mol Neurobiol. 2009;29:845-858. Epub 2009 Mar 14.

How to Treat High-Grade Gliomas
McGirt MJ, Thank KD, Weingart JD, et al. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg. 2009;110:583-588.

Glas M, Happold C, Rieger J, et al. Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. J Clin Oncol. 2009;27:1257-1261. Epub 2009 Feb 2.

Kreisl TN, Kim L, Moore K, et al. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol. 2009;27:740-745. Epub 2008 Dec 29.
 
     
Home | Contact Us | View Account | Need Help?
Johns Hopkins Advanced Studies in Oncology (ISSN-1558-0334) is published by Galen Publishing, LLC, d/b/a ASiM, PO Box 340, Somerville, NJ 08876. (908) 253-9001. Copyright ©2010 by Galen Publishing. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiOncology is a registered trademark of The Healthcare Media Group, LLC.